SCHEMBL574835

SCHEMBL574835

CN1CCN(c2c[c]c(N)cc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.58
GAA P10253 3/20 0.58
ADRA2C P18825 3/20 0.58
KDM4E B2RXH2 3/20 0.58
PTK2B Q14289 2/20 0.58
ALDH1A1 P00352 2/20 0.58
KMT2A Q03164 2/20 0.58
GFER P55789 1/20 0.58
ESR2 Q92731 1/20 0.58
MAPK1 P28482 1/20 0.50
HTT P42858 1/20 0.50
RECQL P46063 1/20 0.50
HTR3A P46098 1/20 0.43
SIRT6 Q8N6T7 2/20 0.43
MEN1 O00255 1/20 0.41
GLA P06280 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CHKA P35790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9213288 0.82 ALDH1A1 (0.50) MAPTGAAKDM4EALDH1A1KMT2A
SCHEMBL21596383 0.81 GAA (0.62) MAPTGAAADRA2CKDM4EKMT2A
SCHEMBL574469 0.78 LGMN (0.50) MAPTGAAKDM4EALDH1A1KMT2A
SCHEMBL28780195 0.78 MAPT (0.48) MAPTGAAADRA2CKDM4EPTK2B
SCHEMBL4170677 0.75 MAPT (0.46) MAPTGAAADRA2CKDM4EPTK2B
SCHEMBL6414948 0.74 MAPT (1.00) MAPTGAAADRA2CKDM4EPTK2B
SCHEMBL6151538 0.74 MAPT (1.00) MAPTGAAADRA2CKDM4EPTK2B
SCHEMBL56547 0.74 MAPT (1.00) MAPTGAAADRA2CKDM4EPTK2B
SCHEMBL591377 0.73 ADRA2C (0.56) MAPTGAAADRA2CKDM4EPTK2B
SCHEMBL18230083 0.73 ALDH1A1 (0.44) MAPTGAAADRA2CKDM4EPTK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8987267-B2 2-substituted-8-alkyl-7-OXO-7,8-dihydropyrido[2,3-D]pyrimidine-6-carbonitriles and uses thereof in treating proliferative disorders Temple University—Of the Commonwealth System of Higher Education (US) 2015-03-24 US claimed
EP-2600719-B1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBONITRILES AND USES THEREOF UNIV TEMPLE (US) 2014-10-08 EP claimed
EP-2600719-A1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBONITRILES AND USES THEREOF Temple University - Of The Commonwealth System of Higher Education (US) 2013-06-12 EP claimed
US-20130131058-A1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D] PYRIMIDINE-6-CARBONITRILES AND USES THEREOF TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2013-05-23 US claimed
WO-2012018540-A1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D] PYRIMIDINE-6-CARBONITRILES AND USES THEREOF TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-02-09 WO claimed
US-8987267-B2 2-substituted-8-alkyl-7-OXO-7,8-dihydropyrido[2,3-D]pyrimidine-6-carbonitriles and uses thereof in treating proliferative disorders Temple University—Of the Commonwealth System of Higher Education (US) 2015-03-24 US disclosed
EP-2600719-B1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBONITRILES AND USES THEREOF UNIV TEMPLE (US) 2014-10-08 EP disclosed
EP-2600719-A1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBONITRILES AND USES THEREOF Temple University - Of The Commonwealth System of Higher Education (US) 2013-06-12 EP disclosed
US-20130131058-A1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D] PYRIMIDINE-6-CARBONITRILES AND USES THEREOF TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2013-05-23 US disclosed
WO-2012018540-A1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D] PYRIMIDINE-6-CARBONITRILES AND USES THEREOF TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131058-A1 2-SUBSTITUTED-8-ALKYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D] PYRIMIDINE-6-CARBONITRILES AND USES THEREOF CDK7, CDK2, CDK8 MAPT 4742/4885GAA 2679/4885ADRA2C 2708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.